ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab.

Oliver W Press et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.